Garrison Bradford & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Garrison Bradford & Associates's ELV Position: Q1 2025 in Review
Garrison Bradford & Associates sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 6,468 shares — an estimated $2.39M sold.
Garrison Bradford & Associates first reported a position in ELV in Q3 2020 and held it in 18 quarters. The position peaked at $3.93M in Q4 2022. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.
- Garrison Bradford & Associates reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
- Garrison Bradford & Associates sold 6,468 Elevance Health shares in Q1 2025, an estimated $2.39M.
- Garrison Bradford & Associates first reported a position in Elevance Health in Q3 2020 and held it in 18 quarters.
- Garrison Bradford & Associates's Elevance Health position peaked at $3.93M in Q4 2022.
- 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.
Based on Garrison Bradford & Associates's 13F filing for Q1 2025, filed 6 May 2025.